期刊文献+

A multiple-reaction-monitoring mass spectrometric method for simultaneous quantitative analysis of five plasma apolipoproteins 被引量:2

A multiple-reaction-monitoring mass spectrometric method for simultaneous quantitative analysis of five plasma apolipoproteins
原文传递
导出
摘要 A multiplexed targeted proteomic assay using a mTRAQ-MRM/MS-based approach was developed and assessed to systematically quantify the relative expressions of five candidate plasma apolipoproteins that have been previously shown to be dysregulated in neuropsychiatric disorders and cognitive dysfunction:apolipoprotein H(APOH),apolipoprotein J(APOJ),apolipoprotein A4(APOA4),apolipoprotein E(APOE),and apolipoprotein D(APOD).The peptides and transitions of each APO were carefully selected according to the tandem MS signals acquired on a TripleTOFTM 5600,followed by optimization of the declustering potential and collision energy voltages for transitions on a QTRAP 5500.Our results showed that the collision energies of mTRAQ-labeled peptides were approximately 15%–20%higher than corresponding non-labeled peptides.Through optimized transitions and parameters,we analyzed the relative abundances of the five APOs in human plasma with and without depletion of high abundant proteins.The results indicated that the MRM signals of four target APOs were significantly increased after depletion,while the MRM signal of one APO,APOD,was decreased.Furthermore,the relative abundances of the five target APOs in healthy human plasma were stable,and the ranking of these proteins according to their MS responses changed slightly.Therefore,we deduced that the rank order of the MS signals for these target proteins can be developed as a diagnostic signature for diseased plasma. A multiplexed targeted proteomic assay using a mTRAQ-MRM/MS-based approach was developed and assessed to systemat- ically quantify the relative expressions of five candidate plasma apolipoproteins that have been previously shown to be dysreg- ulated in neuropsychiatric disorders and cognitive dysfunction: apolipoprotein H (APOH), apolipoprotein J (APOJ), apolipo- protein A4 (APOA4), apolipoprotein E (APOE), and apolipoprotein D (APOD). The peptides and transitions of each APO were carefully selected according to the tandem MS signals acquired on a TripleTOFTM 5600, followed by optimization of the declustering potential and collision energy voltages for transitions on a QTRAP 5500. Our results showed that the collision en- ergies of mTRAQ-labeled peptides were approximately 15%-20% higher than corresponding non-labeled peptides. Through optimized transitions and parameters, we analyzed the relative abundances of the five APOs in human plasma with and without depletion of high abundant proteins. The results indicated that the MRM signals of four target APOs were significantly in- creased after depletion, while the MRM signal of one APO, APOD, was decreased. Furthermore, the relative abundances of the five target APOs in healthy human plasma were stable, and the ranking of these proteins according to their MS responses changed slightly. Therefore, we deduced that the rank order of the MS signals for these target proteins can be developed as a diagnostic signature for diseased plasma.
出处 《Science China Chemistry》 SCIE EI CAS 2014年第5期723-731,共9页 中国科学(化学英文版)
基金 supported by the National Basic Research Program of China(2009CB918300) the National Natural Science Foundation of China(31271189 and 81101009)
关键词 mass spectrometry mTRAQ MRM APOLIPOPROTEIN APO PLASMA 载脂蛋白H 人血浆 多反应监测 定量分析 质谱法 APOE 蛋白质组 认知功能障碍
  • 相关文献

参考文献23

  • 1Frohlich J, Al-Sarraf A. Cardiovascular risk and atherosclerosis prevention. Cardiovasc Pathol, 2013, 22: 16-18.
  • 2Arsenault BJ, Boekholdt SM, Kastelein JJ. Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol, 2011, 8: 197-206.
  • 3Moore RJ, Chamberlain RM, Khuri FR. Apolipoprotein e and the risk of breast cancer in african-american and non-hispanic white women. A review. Oncology, 2004, 66: 79-93.
  • 4Sutcliffe JG, Thomas EA. The neurobiology of apolipoproteins in psychiatric disorders. Mol Neurobiol, 2002, 26: 369-388.
  • 5Chan DC, Watts GF. Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Expert Opin Pharmacother, 2011, 12: 13-30.
  • 6Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicano M, Rizzo C, Scapagnini G, Vasto S. Inflammation, cytokines, immune response, apolipoprotein e, cholesterol, and oxidative stress in alzheimer disease: Therapeutic implications. Rejuvenation Res, 2010, 13: 301- 313.
  • 7Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, Cheng K, Yang de Y, Fan SH, Chen L, Fang L, Xie P. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res, 2012, 11: 1741-1748.
  • 8Xu HB, Zhang RF, Luo D, Zhou Y, Wang Y, Fang L, Li WJ, Mu J, Zhang L, Zhang Y, Xie P. Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. Int J Neuropsycho- pharmacol, 2012, 15: 1413-1425.
  • 9Zhang S, Wen B, Zhou B, Yang L, Cha C, Xu S, Qiu X, Wang Q, Sun H, Lou X, Zi J, Zhang Y, Lin L, Liu S. Quantitative analysis of the human AKR family members in cancer cell lines using the mTRAQ/MRM approach. J Proteome Res, 2013, 12: 2022-2033.
  • 10Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis, 2006, 9: 293-348.

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部